Sunday March 18, 2018
Home Business Startup and a...

Startup and a more competitive India


New Delhi: The growth of several countries in the past have been driven by a need for creating better solutions for existing problems by startup companies. This, along with secure property rights is major differences between organized and unorganized societies.

Innovative enterprise the world over has made nations economically better off and people more prosperous. The most prominent examples that come to mind are those of Germany, Israel and the US.

The East Asian miracle was also based on creating local industries that could assemble parts more productively and at a cost advantage as compared to western countries that lead to their export competitiveness.

Japan’s major companies like Toshiba, Hitachi, and Toyota were once small enterprises. Even countries like China have greatly benefitted from the policies envisaged in the late 1970s in making people more productive and prosperous as mentioned by Deng Xiaoping in 1984 when he focused on using the forces of production for economic development – thus ending the decades-old conception of how society ought to be organised.

The primary point being driven home in all this is that well-designed policies as such greatly assist in making a productive people more prosperous. In a way, the 3Ps of policies, people and productivity lie at the core of becoming a prosperous nation.

India’s earlier economic development model has rarely focused on developing entrepreneurs as a strategic resource for national development.

The colonial hangover in the past has meant that India’s initial years post independence went deeply mistrusting private entrepreneurs and enterprises in doing social good. However, this has resulted in what many people call a “mixed up” economy rather than a mixed economy. This is where Prime Minister Narendra Modi’s speech at the Startup India launch mentioned the role of government to stop over-regulating and letting the people themselves resolve the issues they face.

If one comes to think of it, the jobs that India requires over the next decade – with a million people entering the workforce every month – cannot be provided fully by the formal sector multinationals and government’s public sector enterprises alone. In a way, this presents a sizeable opportunity for India to capitalise on its demographic dividend. However if India continues with is older policies, it may very well end up curtailing private sector development as well as entrepreneurship.

Now, the government rightly recognises the role of entrepreneurs as job creators and capable of absorbing the surging workforce in the decade ahead. The startup plan which has been unveiled before the people has many positives for unleashing the latent ‘Chi’ or the creative force of the Indian economy.

These include doing away with certifications, simplification for opening up a start-up and helping start-ups protect their intellectual property with procedural help as well as financial assistance.

Apart from this, other provisions include creating a fund of funds with a corpus of Rs.10,000 crore (almost $1.5 billion) that has been hailed and scorned at in equal measure due the to public funds being used as venture capital.

Other major announcements deal with the removal of tax for an initial period of three years and further exemption of capital gains tax for incubators investing in startups. Apart from these, the other major announcements deal with setting up of seven research parks and promotion of entrepreneurship in biotechnology.

Taken together, these are bound to help develop a culture of entrepreneurship. However, a significant point is looking at structural issues that hinder entrepreneurship in the Indian context.

The government has done well to draw the attention of youth for pursuing their dream of entrepreneurship, but deeper societal issues must also be addressed for optimal outcomes. Over the next 10 years, India’s aim should be to make the ecosystem of enabling entrepreneurship more robust and making it a more viable career option for individuals wanting to take the plunge. How this will play out will determine India’s ability to leverage its human resources effectively for economic growth and competitiveness.(Amit Kapoor)(IANS)

Click here for reuse options!
Copyright 2016 NewsGram

Next Story

Pentavalent vaccine: Doctors raise red flag

In spite of the data presented in this paper from a large cohort, the authors point out that the evidence is merely circumstantial and not conclusive

the new Hepatitis B vaccine for adults is called Heplisav-B.
India's PV to be reexamined because of its harmful effects. .
  • Pentavalent vaccine was introduced in India six years ago
  • It is since then have been a cause of many deaths
  • Doctors want it to be reexamined before continuing its use

Pentavalent vaccine (PV), that was introduced by India a little over six years ago, doubled the deaths of children soon after vaccination compared to the DPT (Diphtheria-Pertussis-Tetanus) vaccine, according to a new study that calls for a “rigorous review of the deaths following vaccination with PV”.

Health officials have launched a campaign targeting nearly 24 million people with a one-fifth dose of the vaccine. Wikimedia Commons
PV has been cause of many deaths in past years. Wikimedia Commons

Government records show that there were 10,612 deaths following vaccination (both PV and DPT) in the last 10 years. There was a huge increase in these numbers in 2017, which the Health Ministry has promised to study. “The present analysis could be a starting point in the quest to reduce the numbers of such deaths,” authors of the new study say.

The study by Dr Jacob Puliyel, Head of Pediatrics at St Stephens Hospital, and Dr V. Sreenivas, Professor of Biostatistics at the All-India Institute of Medical Sciences (AIIMS), both in New Delhi, is published in the peer-reviewed Medical Journal of Dr D.Y. Patil University.

PV is a combination of the DPT vaccine and two more vaccines against Haemophilus influenza type B (Hib) and hepatitis B. Starting December 2011, PV was introduced into India’s immunisation programme to replace DPT vaccine in a staged manner with a view to adding protection against Hib and Hepatitis B without increasing the number of injections given to infants.

Doctors have raised concerns over these vaccines. Wikimedia Commons
Doctors have raised concerns over these vaccines. Wikimedia Commons

But sporadic reports of unexplained deaths following immunisation with PV had been a matter of concern. Puliyel, Sreenivas and their colleagues undertook the study to find out if these deaths were merely coincidental or vaccine-induced.

The authors obtained data of all deaths reported from April 2012 to May 2016 under the Right to Information Act. Data on deaths within 72 hours of administering DPT and PV from different states were used.

For their study, the authors assumed that all deaths within 72 hours of receiving DPT are natural deaths. Using this figure as the baseline, they presumed that any increase in the number of deaths above this baseline among children receiving PV must be caused by this vaccine.

Also Read: With Medicine Running Out, Venezuelans With Transplant Live in Fear

According to their analysis of the data provided by the government, there were 237 deaths within 72 hours of administering the Pentavalent vaccine — twice the death rate among infants who received DPT vaccine.

Extrapolating the data, the authors have estimated that vaccination of 26 million children each year in India would result in 122 additional deaths within 72 hours, due to the switch from DPT to PV.

“There is likely to be 7,020 to 8,190 deaths from PV each year if data from states with the better reporting, namely Manipur and Chandigarh, are projected nationwide,” their report says.

It is important to make sure that these vaccines are reexamined peroperly. VOA

The authors note that while the study looks at the short-term increase in deaths (within three days of vaccination) it does not calculate the potential benefits of PV on infant mortality, for example by protection against lethal diseases like Haemophilus influenza.

In spite of the data presented in this paper from a large cohort, the authors point out that the evidence is merely circumstantial and not conclusive. “These findings of differential death rates between DPT and PV do call for further rigorous prospective population-based investigations,” the study concludes. IANS